Department of Medicine

Medicine & Life Sciences

1. Safety 100%
2. Therapeutics 97%
3. Kidney 93%
4. Systematic Reviews 84%
5. Odorants 81%
6. Ankylosing Spondylitis 80%
7. Registries 76%
8. Bone Density 75%
9. HIV 73%
10. Osteoporotic Fractures 71%
11. Opioid Analgesics 68%
12. Guidelines 65%
13. Population 61%
14. Placebos 59%
15. Colonoscopy 59%
16. Advisory Committees 58%
17. Phototoxic Dermatitis 54%
18. Mortality 54%
19. Lung 53%
20. Chronic Obstructive Pulmonary Disease 53%
21. Health 53%
22. Confidence Intervals 52%
23. Randomized Controlled Trials 52%
24. Physicians 50%
25. Asthma 47%
26. Pain 46%
27. Osteoporosis 45%
28. Anesthesia 44%
29. Pharmaceutical Preparations 44%
30. Delivery of Health Care 41%
31. Cytomegalovirus 41%
32. Psoriatic Arthritis 41%
33. Infections 40%
34. Barrett Esophagus 40%
35. Serum 40%
36. Transplants 39%
37. Exercise 38%
38. Veterans 38%
39. Primary Health Care 38%
40. Education 37%
41. Skin 37%
42. Phosphotransferases 37%
43. Colorectal Neoplasms 37%
44. Coronavirus 37%
45. Cohort Studies 37%
46. Bone and Bones 36%
47. Odds Ratio 36%
48. Transplant Recipients 36%
49. Meta-Analysis 35%
50. Spine 35%
51. T-Lymphocytes 34%
52. Wounds and Injuries 34%
53. Endoscopy 33%
54. Hospitalization 33%
55. Practice Guidelines 33%
56. Heart Diseases 32%
57. Child 32%
58. Neoplasms 31%
59. Quality of Life 31%
60. Brain 31%
61. Incidence 31%
62. Communication 31%
63. Pandemics 31%
64. Insulin 30%
65. Glucose 30%
66. Early Detection of Cancer 30%
67. Pediatrics 30%
68. secukinumab 29%
69. Obstructive Lung Diseases 29%
70. Mucosal-Associated Invariant T Cells 29%
71. Tuberculosis 29%
72. Genes 29%
73. Hypertension 29%
74. Hip Fractures 28%
75. Stroke 28%
76. Costs and Cost Analysis 28%
77. Elderly 28%
78. Proteins 28%
79. Toxicology 28%
80. Accidental Falls 28%
81. Rheumatoid Arthritis 28%
82. Electronic Health Records 28%
83. Low Back Pain 26%
84. Inflammation 26%
85. Blood Pressure 26%
86. Clinical Trials 26%
87. Gastroesophageal Reflux 25%
88. Type 1 Diabetes Mellitus 25%
89. Critical Illness 25%
90. Hemorrhage 25%
91. Kidney Transplantation 25%
92. Intensive Care Units 25%
93. Tumor Necrosis Factor Inhibitors 25%
94. Prospective Studies 25%
95. Liver Transplantation 24%
96. Mutation 24%
97. Allografts 24%
98. Steroids 23%
99. Substance-Related Disorders 23%
100. Hip 23%